Cryoport, Inc., a global cryogenic logistics company dedicated to the life sciences industry, has expanded its portfolio of cold chain logistics solutions with the launch of its ‘Cryoport. Certified. Cool.’ It will be branded as “C3™”, in support of the new high-value regenerative therapies that require temperature-controlled transportation within the 2°C - 8°C temperature range during the logistics of processing these new therapies.
Cryoport’s C3™ shipper offers the first 2°C - 8°C shipping offering designed for integration into its CryoportalTM Logistics Management Platform. C3™ provides enhanced, real-time visibility, security and risk mitigation from temperature excursions for the client’s critical biological commodities. The introduction of C3™ means that Cryoport can support the entire logistics continuum for regenerative medicine clinical and commercial programs.
Cryoport strategically selected the established, validated, and reusable Credo CubeTM from Pelican BioThermal for its temperature protection, engineered the Smartpak II™ Condition Monitoring System, which provides real-time visibility into the location and key aspects of critical shipments and, then, integrates the system into its Cryoportal™ Logistics Management Platform for cold chain transparency, monitoring and responsiveness. C3™ includes Cryoport’s 24/7/365 Client Support, which monitors shipments and takes action to mitigate risks when they occur.
C3™demonstrates Cryoport’s ability to scientifically design and implement logistics products for life sciences that protect clients’ valuable biologic materials, including for regenerative therapies, which the company says is its most rapidly growing market.
